123994-74-1 Usage
Type of Compound
Chemical compound with potential pharmacological activity
Type of Inhibitor
Selective Janus kinase (JAK) 1 and 2 inhibitor
Medical Use
Treatment of certain types of myelofibrosis and polycythemia vera (both rare bone marrow diseases)
Mechanism of Action
Inhibits the JAK-STAT signaling pathway, which plays a key role in the regulation of immune function and inflammation
Benefits
Shows promise in reducing symptoms and improving quality of life for patients with myelofibrosis and polycythemia vera
Importance
An important therapeutic option for individuals suffering from these rare blood disorders
Check Digit Verification of cas no
The CAS Registry Mumber 123994-74-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,9,9 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 123994-74:
(8*1)+(7*2)+(6*3)+(5*9)+(4*9)+(3*4)+(2*7)+(1*4)=151
151 % 10 = 1
So 123994-74-1 is a valid CAS Registry Number.
123994-74-1Relevant articles and documents
Structure-Activity Relationships of N2-Substituted Guanines as Inhibitors of HSV1 and HSV2 Thymidine Kinases
Hildebrand, Catherine,Sandoli, Daniele,Focher, Federico,Gambino, Joseph,Ciarrocchi, Giovanni,et al.
, p. 203 - 206 (2007/10/02)
A series of N2-phenylguanines was synthesized and tested for inhibition of the thymidine kinases encoded by Herpes simplex viruses type 1 and type 2.Compounds with hydrophobic, electron-attracting groups in the meta position of the phenyl ring